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Proline is a unique amino acid owing to the relatively small energy difference
between the cis and trans conformations of its peptide bond. The X–Pro imide
bond readily undergoes cis–trans isomerization in the context of short peptides
as well as some proteins. However, the direct detection of cis–trans proline
isomerization in folded proteins is technically challenging. NMR spectroscopy is
well suited to the direct detection of proline isomerization in folded proteins.
It is less clear how well X-ray crystallography can reveal this conformational
exchange event in folded proteins. Conformational heterogeneity owing to cis–
trans proline isomerization in the Src homology 2 (SH2) domain of the IL-2-
inducible T-cell kinase (ITK) has been extensively characterized by NMR. Using
the ITK SH2 domain as a test system, an attempt was made to determine
whether proline isomerization could be detected in a crystal structure of the ITK
SH2 domain. As a first step towards this goal, the purification, crystallization and
preliminary characterization of the ITK SH2 domain are described.
1. Introduction
Planar peptide bonds within folded proteins show an overwhelming
preference for the trans conformation (Stewart et al., 1990). One
notable exception to this conformational preference is the X–proline
imide bond (where X is any amino acid), which can adopt either the
cis or trans conformation owing to the small energy difference
(2.09 kJ mol1) between the cis and trans conformers (Maigret et al.,
1970). A survey of protein structures shows that 5.2% of X–proline
imide bonds occur in the cis conformation, compared with 0.03%
of nonproline peptide bonds (Weiss et al., 1998). Additionally, the
activation-energy barrier for cis–trans isomerization about an X–
proline imide bond is lower than that for a nonproline peptide bond
(54.43 versus 83.74 kJ mol1, respectively; Schulz & Schirmer, 1979;
Jorgensen & Gao, 1988; Schnur et al., 1989). Thus, a proline-
containing polypeptide has the ability to exist in either the cis or trans
conformation about the X–proline imide bond or in some cases exist
in an equilibrium that consists of both the cis and trans conformers
(Andreotti, 2003).
It has long been appreciated that proline isomerization plays a role
in controlling the rate of protein folding (Wedemeyer et al., 2002;
Schmid et al., 1993). More recently, this conformational exchange
event has been shown to modulate a variety of processes, including
ion-channel gating (Lummis et al., 2005), histone lysine methylation
(Nelson et al., 2006), phage infectivity (Eckert et al., 2005), ligand-
binding specificity (Breheny et al., 2003; Santiveri et al., 2004), enzyme
function (Grochulski et al., 1994; OuYang et al., 2008), amyloid plaque
formation (Pastorino et al., 2006; Eakin et al., 2006) and cell signaling
(Brazin et al., 2002; Zhou et al., 2000; Wulf et al., 2005; Yaffe et al.,
1997; Fischer & Aumu¨ller, 2003).
While the biological significance of proline isomerization is
becoming evident, the detection of proline isomerization in proteins
is still technically challenging. Proline isomerization evades detection
by most biochemical techniques. In fact, in most low-resolution
crystal structures of proteins the X–proline imide-bond conformer is
presumed to adopt the trans conformation. It is therefore possible
that proline isomerization is underestimated among the protein
structures available in the Protein Data Bank. The cis- or trans-
proline imide-bond conformers of several proteins have been crys-
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tallized separately under different crystallization conditions (Cotton
et al., 1979; Hynes & Fox, 1991; Loll & Lattman, 1989; Szebenyi &
Moffat, 1986). However, the simultaneous detection of both proline
imide-bond conformers of a protein in a given crystal structure has
been rare (Svensson et al., 1992). Moreover, since isomerizing proline
residues are frequently present in flexible loops, the poor electron
density corresponding to these regions potentially obscures the
underlying conformational heterogeneity (Feng et al., 1997; Mallis et
al., 2002; Grochulski et al., 1994; Golmohammadi et al., 1993).
Conformational heterogeneity owing to an isomerizing proline
(Pro287) within the Src homology 2 (SH2) domain of the IL-2-
inducible T-cell kinase (ITK) has been extensively characterized by
NMR (Mallis et al., 2002; Breheny et al., 2003; Pletneva et al., 2006;
Severin et al., 2009). Both the cis- and trans-imide bond-containing
SH2-domain structures have been solved from a single NMR data set
(Mallis et al., 2002). Moreover, cis–trans isomerization about the ITK
SH2 Asn286–Pro287 imide bond has been shown to direct the ligand-
binding preference of the ITK SH2 domain, which may have
functional implications in T-cell signaling (Breheny et al., 2003). The
trans-imide bond-containing conformer of the ITK SH2 domain has
higher affinity for a classical phosphotyrosine-containing ligand
(Pletneva et al., 2006). The cis-imide bond-containing conformer of
the ITK SH2 domain mediates a nonclassical interaction with the ITK
SH3 domain (Severin et al., 2009). Given that the ITK SH2 domain
adopts two interconverting conformers in solution, we decided to
investigate the extent to which this conformational heterogeneity can
be observed in a structure of the ITK SH2 domain derived from
X-ray crystallographic approaches. The description of the initial
crystallization conditions of the ITK SH2 domain provided here is the
first step towards addressing this question.
2. Materials and methods
2.1. Cloning and expression
The construct for the ITK SH2 domain (ITK; gene ID 16428) has
been described previously (Brazin et al., 2000). Briefly, the mouse
ITK SH2 domain (residues 231–338) was cloned into the pGEX-2T
vector (GE Healthcare) with an N-terminal (vector-derived) GST tag
and a thrombin cleavage site between the GST tag and the ITK SH2
domain. The construct was verified by sequencing at the Iowa State
DNA Sequencing and Synthesis Facility prior to transformation into
Escherichia coli strain BL21 (DE3) cells (Novagen). For protein
expression, cells were grown in LB medium containing 100 mg ml1
ampicillin at 310 K until the optical density of the culture at 600 nm
reached 0.7. The temperature of the culture was then lowered to
293 K and it was induced with 1 mM -d-1-thiogalactopyranoside
(IPTG) for 24 h. The cells were harvested and resuspended in lysis
buffer (50 mM HEPES pH 7.4, 75 mM NaCl, 2 mM DTT, 0.02%
NaN3) with 0.5 mg ml
1 lysozyme and stored at 193 K. To produce
selenomethionyl (SeMet) labeled ITK SH2 domain, cells were grown
in modified M9 medium containing l-selenomethionine (Calbio-
chem) as described previously (Van Duyne et al., 1993). The incor-
poration of l-selenomethionine was confirmed by MALDI–TOF
mass-spectrometric analysis of the tryptic digests of the labeled
protein at the Iowa State Protein Facility.
2.2. Protein purification
The ITK SH2 domain was purified as described previously with
several modifications (Brazin et al., 2000). The cells were lysed upon
thawing at room temperature by the addition of protease inhibitor
(1 mM PMSF) and DNase I (Sigma; 50 ml of 10 mg ml1 stock). The
cell lysate was clarified by centrifugation and the resulting super-
natant was loaded onto two 5 ml glutathione–agarose columns
(Sigma). Each column was washed with 200 ml lysis buffer (50 mM
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Figure 1
Characterization of the ITK SH2 domain. (a) Chromatogram of the Sephacryl
S-100 HR gel-filtration column along with SDS–PAGE analysis of the column
fractions (inset). (b, c) MALDI–TOF MS analysis of the tryptic digests of native
ITK SH2 domain (b) and SeMet-labelled ITK SH2 domain (c). Incorporation of
SeMet leads to an increase in the mass of the ITK SH2-domain peptide fragment
EGAFMVR from 809 to 857 Da.
HEPES pH 7.4, 75 mM NaCl, 2 mM DTT, 0.02% NaN3). The GST-
fusion protein was eluted in lysis buffer containing 10 mM gluta-
thione. The protein was concentrated and buffer-exchanged in order
to remove the glutathione and was then cleaved overnight with
thrombin (Calbiochem) at room temperature. After cleavage, the
protein was passed over two 5 ml glutathione–agarose columns to
remove GST, concentrated and loaded onto a gel-filtration column
(a C26/100 column packed with Sephacryl S-100 HR resin; GE
Healthcare) equilibrated with the same buffer (50 mM HEPES pH
7.4, 75 mM NaCl, 2 mM DTT, 0.02% NaN3). Fractions containing
protein were analyzed for purity by SDS–PAGE; the pure fractions
were pooled and the salt concentration of the buffer was increased
from 75 to 150 mM NaCl. The pooled protein was then passed over
a 10 ml benzamidine column (GE Healthcare) equilibrated with the
same buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 2 mM DTT,
0.02% NaN3). The purified ITK SH2 domain was concentrated to
13.5 mg ml1 in the same buffer (50 mM HEPES pH 7.4, 150 mM
NaCl, 2 mM DTT, 0.02% NaN3) and filter-sterilized prior to setting
up crystal trays. The final purified ITK SH2 domain has two addi-
tional vector-derived N-terminal residues (G and S) and eight vector-
derived C-terminal residues (GSPGIHRD).
2.3. Crystallization
The ideal protein concentration for crystallization screening of the
ITK SH2 domain was determined to be 1.35 mg ml1 using the PCT
Pre-Crystallization test (Hampton Research). Initial screening was
performed at 1.35 mg ml1 ITK SH2 domain using Crystal Screen
and Crystal Screen 2 (Hampton Research). Crystals were screened at
room temperature and 277 K by the hanging-drop method in vapor-
diffusion VDX plates (Hampton Research). 2 ml protein solution was
mixed with an equal volume of well solution and the mixture was
equilibrated against 500 ml well solution. Microcrystals were observed
after 2 d at room temperature in condition No. 40 of Crystal Screen
[20% 2-propanol, 0.1 M sodium citrate pH 5.6, 20%(w/v) PEG 4000].
After several rounds of buffer optimization and additional screening
(Additive Screen and Detergent Screen from Hampton Research),
single crystals that diffracted to 2.4 A˚ resolution were obtained.
The final crystals were grown by mixing 3.5 ml of a 1:1 ratio of
1.35 mg ml1 ITK SH2 domain and reservoir solution [0.1 M sodium
citrate pH 5.3, 10% 2-propanol, 20%(w/v) PEG 4000 and 2 mM DTT]
with 0.5 ml (12.5 mM final concentration) of a 100 mM stock solution
of glycyl-glycyl-glycine (Sigma) as an additive in a final drop volume
of 4 ml. All drops were equilibrated against 500 ml reservoir solution.
The plate-like crystals grew to approximately 50–100 mm in two
weeks and were flash-cooled directly (without additional cryopro-
tectants) in liquid nitrogen.
2.4. X-ray diffraction
Crystals were screened on a Rigaku R-AXIS IV++ rotating-anode/
image-plate system using Cu K radiation and an Osmic confocal
optics system at Iowa State University. Diffraction data for native
and SeMet-labeled ITK SH2 domain were collected from single
crystals at a crystal-to-detector distance of 140 mm on beamline 4.2.2
of the Advanced Light Source, Lawrence Berkeley Laboratory. The
crystal was rotated through 180 with a 1 oscillation range per frame.
For the SeMet crystals, complete anomalous data sets were obtained
at wavelengths corresponding to the peak absorbance (0.9790 A˚), the
inflection point (0.9793 A˚) and a remote wavelength (0.9951 A˚) from
the absorption edge of selenium. The program d*TREK (Pflugrath,
1999) was used to index, integrate, scale and merge the intensities,
which were then converted to structure factors using the TRUN-
CATE program from CCP4 (Collaborative Computational Project,
Number 4, 1994; French & Wilson, 1978).
3. Results and discussion
The ITK SH2 domain was purified to greater than 98% homogeneity
(as assessed by Coomassie Blue staining of an SDS–PAGE gel) for
crystallization screening (Fig. 1a). Incorporation of SeMet in the
SeMet-labeled ITK SH2 domain was confirmed by MALDI–TOF MS
analysis of tryptic digests of labeled and unlabeled ITK SH2 domains.
Incorporation of SeMet leads to an increase in mass of the ITK SH2-
domain peptide fragment EGAFMVR from 809 to 857 Da (Figs. 1b
and 1c, respectively). The ideal protein concentration for crystal-
lization screening was determined to be 1.35 mg ml1 using the PCT
Pre-Crystallization test (Hampton Research). Indeed, crystallization
screens (Crystal Screens and Crystal Screen 2, Hampton Research)
set up using a higher ITK SH2 concentration of 13.5 mg ml1 resulted
in immediate precipitation in 90% of the conditions tested. The
crystallization communications
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Figure 2
A representative crystal of the ITK SH2 domain. The crystals are approximately
50–100 mm in size.
Figure 3
X-ray diffraction image collected from a native crystal of the ITK SH2 domain.
crystallization concentration requirement (1.35 mg ml1) of the ITK
SH2 domain could be a reflection of increased stability of the ITK
SH2 domain at lower protein concentrations: while a 1.35 mg ml1
solution of the ITK SH2 domain was stable at 277 K for several
weeks, a 13.5 mg ml1 solution of the ITK SH2 domain showed
visible precipitate formation within a week at 277 K. Crystallization
screens were set up at both room temperature and 277 K. Micro-
crystals were observed in Crystal Screen condition No. 40 [20%
2-propanol, 0.1 M sodium citrate pH 5.6, 20%(w/v) PEG 4000] in 2 d
at room temperature. Microcrystals were also observed after one
month at 277 K under the same buffer conditions. Larger plate-like
crystals that diffracted were obtained after optimization of the buffer
conditions and additional (additive) screening (Fig. 2). The final
crystallization conditions were 0.1 M sodium citrate pH 5.3, 10%
2-propanol, 20%(w/v) PEG 4000, 2 mM DTT with 12.5 mM glycyl-
glycyl-glycine as an additive (see x2). SeMet-incorporated ITK SH2
domain crystals were also obtained using the same crystallization
conditions. The native and SeMet-labeled crystals diffracted to
approximately 2.4 A˚ resolution (Fig. 3). The space group was deter-
mined to be I222, with unit-cell parameters a = 53.6, b = 57.4,
c = 83.2 A˚ and a = 53.5, b = 57.4, c = 81.3 A˚ for the native and SeMet-
labeled crystals, respectively. A summary of the data-collection
statistics is provided in Table 1. The calculated Matthews coefficient
(VM) of 2.35 A˚
3 Da1, with a solvent content of 47.7%, suggests the
presence of one molecule per asymmetric unit. Efforts to solve the
structure using the multiwavelength anomalous diffraction data are
currently under way.
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